On the other hand, the aberrant overexpression of CSN subunits, most prominently CSN5 and CSN6, has been observed in human cancers including breast cancer [71], glioblastoma [72], and pancreatic carcinoma [73]. This evidence concerns the gene COPS5 and exocrine pancreatic carcinoma.